Načítá se...
COVID‐SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults
BACKGROUND/OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection causes high morbidity and mortality in older adults with chronic illnesses. Several trials are currently underway evaluating the antimalarial drug hydroxychloroquine as a potential treatment for acute infec...
Uloženo v:
| Vydáno v: | J Am Geriatr Soc |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280600/ https://ncbi.nlm.nih.gov/pubmed/32441771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.16623 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|